Xiangming Na

Title: Innovations of Xiangming Na in Vaccine Development

Introduction

Xiangming Na is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly through his innovative approach to microencapsulation technology. His work focuses on creating effective and safe vaccines that can enhance immunization strategies.

Latest Patents

Xiangming Na holds a patent for a microcapsule-based vaccine. This vaccine comprises an antigen and a matrix of biodegradable polymer blend. The polymer blend includes a hydrophobic polymer and an amphiphilic block copolymer. The vaccine is designed in the form of microcapsules that feature a multi-cavity structure inside. The average particle diameter of the microcapsules is preferably between 10-100 μm, with an optimal range of 30-60 μm. The preparation method involves creating porous microspheres from the polymer blend, mixing these microspheres with an antigen-containing solution, and sealing the openings of the microspheres to form a microcapsule loaded with the antigen.

Career Highlights

Xiangming Na is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on public health through improved vaccine formulations.

Collaborations

Xiangming Na collaborates with notable colleagues, including Guanghui Ma and Wei Wei. Their combined expertise contributes to advancing research in vaccine technology.

Conclusion

Xiangming Na's innovative work in microcapsule-based vaccines represents a significant advancement in immunization technology. His contributions are poised to enhance vaccine efficacy and safety, ultimately benefiting public health.